Savara announces new employment inducement grant

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to seven new employees. on april 9, 2025, the compensation committee of savara's board of directors granted the inducement awards to seven new employees who recently joined the company. the inducement awards consist of options to purchase an aggregate of 107,000 shares of the company's common stock and restri.
SVRA Ratings Summary
SVRA Quant Ranking